Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “filgrastim” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 16
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 16 pipeline programs matching "filgrastim" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

16 results for “filgrastim” Back to intelligence hub

Search results

  1. Tbo-filgrastim

    Teva Pharma GmbH

    Healthy Participants

    phase 3 small molecule terminated

    1 trial
  2. filgrastim

    Solid Biosciences

    Ovarian Cancer

    phase 3 mab completed

    1 trial
  3. filgrastim

    Hospital Authority, Hong Kong

    Brain and Central Nervous System Tumors

    phase 3 mab completed

    2 trials
  4. filgrastim

    Children's Hospital of Fudan University

    Neuroblastoma

    phase 3 mab completed

    1 trial
  5. filgrastim

    Solid Biosciences

    Lung Cancer

    phase 3 mab active

    1 trial
  6. filgrastim

    Solid Biosciences

    Lymphoma

    phase 3 mab active

    2 trials
  7. lipegfilgrastim

    Teva Pharma GmbH

    Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

    phase 3 small molecule completed

    1 trial
  8. pegfilgrastim

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 mab active

    1 trial
  9. PEGFILGRASTIM , Rinatabart Sesutecan

    Genmab A/S

    Locally advanced or metastatic Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial
  10. filgrastim

    Ultragenyx UK Limited

    Shwachman Syndrome

    phase 2 small molecule completed

    1 trial
  11. tbo-filgrastim

    Teva Pharma GmbH

    Neutropenia

    phase 2 small molecule completed

    1 trial
  12. Filgrastim

    Rocket Pharmaceuticals B.V.

    Fanconi Anemia

    phase 1 mab terminated

    1 trial
  13. Lipegfilgrastim

    Teva Pharma GmbH

    Ewing Family of Tumors, Rhabdomyosarcoma

    phase 1 small molecule completed

    1 trial
  14. Pegfilgrastim

    Biotech Pharmaceutical Co.,

    Breast Cancer

    phase 1 small molecule completed

    1 trial
  15. filgrastim

    Ultragenyx UK Limited

    Fanconi's Anemia

    phase 1 small molecule active

    1 trial
  16. lipegfilgrastim

    Teva Pharma GmbH

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.